Third-party litigation funding has become an increasingly significant feature of New York civil litigation, particularly in personal injury matters. Historically, these arrangements operated largely as private financing transactions, with limited regulatory oversight of funding practices, financial relationships, and industry reporting.
New York's Consumer Litigation Funding Act marks an important first step toward changing that landscape. Effective June 17, 2026, the legislation established consumer protections and restrictions on funding practices under Article 10 of the New York Financial Services Law. The law also introduces registration and annual reporting requirements administered by the New York State Department of Financial Services (DFS). The Act is not retroactive and is not applicable to funding contracts entered into prior to the effective date of the Act.
For insurers, defendants, and their counsel, these developments represent meaningful progress toward greater accountability in litigation funding, while highlighting areas where continued regulatory scrutiny and transparency remain important.
Key Regulatory Dates and Requirements
The Act's implementation occurs in phases:
June 17, 2026 Consumer protections, contractual disclosures, and restrictions on funding practices became effective.
February 13, 2027 Registration applications are due, and reporting provisions become effective, subject to DFS implementation procedures.
January 31, 2028, and annually thereafter Funding companies must submit reports to DFS regarding the preceding calendar year's funding activity.
Within 90 days of report submission DFS must publish reported information in a manner that protects the identities of funding companies and consumers.
Companies that submit registration applications within 180 days after DFS first makes applications available may continue entering into funding contracts while their applications remain pending.
DFS offers email alerts about the Litigation Funding Act, including when registration instructions have been added to the DFS website; subscription options can be accessed here:
New York State Department of Financial Services
Which Funding Transactions Are Regulated?
The statute is directed at consumer litigation funding, not the entire commercial litigation finance industry.
Under Financial Services Law § 1001, a covered transaction involves a litigation funding company providing no more than $500,000 to a natural person in exchange for repayment from the potential proceeds of that person's civil claim. Notably, the Act prohibits providing more than five hundred thousand dollars to a consumer to fund litigation.
Importantly, the definition of a covered consumer requires both:
New York residency or domicile: The individual must reside or be domiciled in New York.
A New York lawsuit: The underlying claim must be filed, or expected to be filed, in a New York state or federal court.
Both conditions matter. The statute does not cover every lawsuit pending in New York or every funding arrangement involving a New York resident. For example, a Connecticut resident pursuing a personal injury action in New York would not satisfy the statute's consumer definition merely because the lawsuit is pending in New York. Likewise, a New York resident pursuing litigation exclusively in another state would not satisfy the New York-court requirement.
The statute is not expressly limited to bodily injury claims. Its definition of a legal claim encompasses civil claims generally, meaning qualifying individual claimants pursuing other types of civil litigation may also fall within its protections.
However, commercial litigation financing involving corporations, business entities, or financing provided directly to law firms is not generally within the statute's defined consumer funding transaction.
Nor is coverage determined solely by the funding company's location. An out-of-state funding company entering into covered transactions with qualifying New York consumers may be subject to the law.
The Beginning of Greater Regulatory Oversight
New York's Consumer Litigation Funding Act represents a significant transition from largely private financing arrangements toward a regulated industry with defined consumer protections, restrictions on financial relationships, and recurring regulatory reporting.
The legislation is an important starting point, particularly in addressing referral compensation, potential conflicts of interest, and funder involvement in litigation decisions. However, its limited application to defined consumer transactions, together with the confidentiality of company-specific reporting, leaves substantial areas of the broader litigation finance industry outside its transparency requirements.
As DFS implements registration and reporting, continued regulatory scrutiny will be important in evaluating funding practices, identifying emerging risks, and determining whether additional oversight or disclosure requirements are warranted.
In Part 2 of this series, we examine the Act's contract requirements, funding restrictions, and prohibitions on referral relationships and financial incentives involving attorneys, law firms, medical providers, and litigation funding companies.
For questions about New York's Consumer Litigation Funding Act and its potential impact on litigation strategy, claims handling, risk management, or compliance considerations, please contact the authors or a member of Gerber Ciano Kelly Brady LLP's Litigation and Trial Practice Group.
Our team continues to monitor developments in litigation funding and related regulatory matters and is available to discuss how these changes may affect insurers, businesses, and litigation stakeholders throughout New York.
Kelly E. Petter
Partner
(860) 516-9144